ZNF440 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.192000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.011600E-01
Normal-vs-Stage2
2.903200E-01
Normal-vs-Stage3
6.808000E-01
Normal-vs-Stage4
2.166000E-01
Stage1-vs-Stage2
4.858000E-02
Stage1-vs-Stage3
4.666000E-02
Stage1-vs-Stage4
7.199200E-01
Stage2-vs-Stage3
1.162430E-01
Stage2-vs-Stage4
3.428200E-01
Stage3-vs-Stage4
1.257560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.223400E-01
Normal-vs-AfricanAmerican
7.371200E-01
Normal-vs-Asian
3.365600E-01
Caucasian-vs-AfricanAmerican
3.182800E-01
Caucasian-vs-Asian
7.542200E-01
AfricanAmerican-vs-Asian
3.348400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.262600E-01
Normal-vs-Female
3.127200E-01
Male-vs-Female
5.327600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.421400E-01
Normal-vs-Age(41-60Yrs)
2.149800E-01
Normal-vs-Age(61-80Yrs)
3.940400E-01
Normal-vs-Age(81-100Yrs)
4.215400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.086600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.913400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.315200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.669390E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.050200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.132200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.172400E-01
Normal-vs-Daily Drinker
5.120000E-01
Normal-vs-Weekly Drinker
6.058400E-01
Normal-vs-Occasional Drinker
1.077980E-01
Normal-vs-Social Drinker
3.155200E-01
Non Drinker-vs-Daily Drinker
6.847400E-01
Non Drinker-vs-Weekly Drinker
8.483400E-01
Non Drinker-vs-Occasional Drinker
7.026200E-02
Non Drinker-vs-Social Drinker
6.377200E-01
Daily Drinker-vs-Weekly Drinker
6.598200E-01
Daily Drinker-vs-Occasional Drinker
3.746400E-01
Daily Drinker-vs-Social Drinker
9.822400E-01
Weekly Drinker-vs-Occasional Drinker
1.385620E-01
Weekly Drinker-vs-Social Drinker
6.161800E-01
Occasional Drinker-vs-Social Drinker
2.622200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.702400E-02
Normal-vs-Grade 2
1.318040E-02
Normal-vs-Grade 3
1.225630E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.826380E-02
Grade 1-vs-Grade 3
2.988000E-02
Grade 1-vs-Grade 4
4.702400E-02
Grade 2-vs-Grade 3
9.711000E-01
Grade 2-vs-Grade 4
1.318040E-02
Grade 3-vs-Grade 4
1.225630E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.968200E-01
Normal-vs-NonDiabetic
3.257000E-01
Diabetic-vs-NonDiabetic
2.217400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.579600E-01
Normal-vs-NoPancreatitis
3.844000E-01
Pancreatitis-vs-NoPancreatitis
9.349600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.278800E-01
Normal-vs-N1
3.190000E-01
N0-vs-N1
6.655800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.192840E-01
Normal-vs-TP53-NonMutant
2.825000E-01
TP53-Mutant-vs-TP53-NonMutant
1.006380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
